Benchmark helps deliver improved healthcare products and welfare services to the global aquaculture and livestock industries. Rising demand from clients for its products and services to manage sustainability practice and performance underlines BMK's opportunity for significant organic and external growth.
02 Apr 2020
Underpinned by cash and essential products
In today’s trading update, BMK has highlighted that it is well supported by strong financial liquidity and a resilient Genetics division. BMK also benefits from holding sufficient stocks of Animal Health products to support trading. However, the Advanced Nutrition division is likely to face a material impact on demand caused by lower global demand for shrimp.
The cash reserves, resilience of Genetics and Animal Health divisions, and long-term fundamentals including the Company’s positioning in the food supply chain, all remain defensive factors. This leaves BMK well positioned once the crisis has abated. We look forward to updating our forecasts in late May to reflect interim results / Q4’19 reporting.